Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1953 1
1954 1
1955 1
1956 1
1958 2
1960 5
1962 2
1963 3
1964 4
1965 5
1966 3
1967 5
1968 1
1969 6
1970 3
1971 4
1972 3
1973 7
1974 5
1975 10
1976 12
1977 10
1978 7
1979 12
1980 11
1981 15
1982 11
1983 21
1984 32
1985 19
1986 20
1987 28
1988 31
1989 30
1990 22
1991 36
1992 25
1993 20
1994 32
1995 44
1996 41
1997 49
1998 55
1999 54
2000 61
2001 46
2002 58
2003 69
2004 61
2005 69
2006 104
2007 86
2008 106
2009 110
2010 101
2011 94
2012 97
2013 99
2014 90
2015 108
2016 105
2017 103
2018 98
2019 115
2020 115
2021 148
2022 135
2023 134
2024 156
2025 139
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,973 results

Results by year

Filters applied: . Clear all
Page 1
Gastrointestinal stromal tumours.
Blay JY, Kang YK, Nishida T, von Mehren M. Blay JY, et al. Among authors: nishida t. Nat Rev Dis Primers. 2021 Mar 18;7(1):22. doi: 10.1038/s41572-021-00254-5. Nat Rev Dis Primers. 2021. PMID: 33737510 Review.
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial.
Kadowaki T, Isendahl J, Khalid U, Lee SY, Nishida T, Ogawa W, Tobe K, Yamauchi T, Lim S; STEP 6 investigators. Kadowaki T, et al. Among authors: nishida t. Lancet Diabetes Endocrinol. 2022 Mar;10(3):193-206. doi: 10.1016/S2213-8587(22)00008-0. Epub 2022 Feb 4. Lancet Diabetes Endocrinol. 2022. PMID: 35131037 Clinical Trial.
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
Demetri GD, Reichardt P, Kang YK, Blay JY, Rutkowski P, Gelderblom H, Hohenberger P, Leahy M, von Mehren M, Joensuu H, Badalamenti G, Blackstein M, Le Cesne A, Schöffski P, Maki RG, Bauer S, Nguyen BB, Xu J, Nishida T, Chung J, Kappeler C, Kuss I, Laurent D, Casali PG; GRID study investigators. Demetri GD, et al. Among authors: nishida t. Lancet. 2013 Jan 26;381(9863):295-302. doi: 10.1016/S0140-6736(12)61857-1. Epub 2012 Nov 22. Lancet. 2013. PMID: 23177515 Free PMC article. Clinical Trial.
Retraction.
Hiramatsu Y, Nishida T, Nugraha DK, Osada-Oka M, Nakane D, Imada K, Horiguchi Y. Hiramatsu Y, et al. Among authors: nishida t. Sci Adv. 2025 Jan 3;11(1):eadv4615. doi: 10.1126/sciadv.adv4615. Epub 2025 Jan 1. Sci Adv. 2025. PMID: 39742501 Free PMC article. No abstract available.
Comparison of HLA-haploidentical donors with post-transplant cyclophosphamide versus HLA-matched unrelated donors in peripheral blood stem cell transplantation for acute myeloid leukaemia.
Moriguchi M, Nakamae H, Nishimoto M, Sugita J, Yanada M, Toubai T, Hasegawa Y, Hino M, Nishida T, Kurita N, Sawa M, Fukuda T, Jinguji A, Ota S, Matsuoka KI, Eto T, Hiramoto N, Ando T, Kawamura K, Kanda Y, Atsuta Y, Ohbiki M, Nakasone H, Konuma T. Moriguchi M, et al. Among authors: nishida t. Br J Haematol. 2024 Dec;205(6):2376-2386. doi: 10.1111/bjh.19825. Epub 2024 Oct 22. Br J Haematol. 2024. PMID: 39439234
Tranexamic acid and trauma-induced coagulopathy.
Nishida T, Kinoshita T, Yamakawa K. Nishida T, et al. J Intensive Care. 2017 Jan 20;5:5. doi: 10.1186/s40560-016-0201-0. eCollection 2017. J Intensive Care. 2017. PMID: 28729903 Free PMC article. Review.
Heterogeneity of Survival Benefit Conferred By Letermovir.
Akahoshi Y, Nakasone H, Takenaka K, Ara T, Tada Y, Doki N, Uchida N, Tanaka M, Hasegawa Y, Takeda W, Nishida T, Ishikawa J, Kurita N, Sawa M, Onizuka M, Kako S, Fujiwara SI, Kataoka K, Kawamura K, Fukuda T, Atsuta Y, Yakushijin K, Kanda Y. Akahoshi Y, et al. Among authors: nishida t. Transplant Cell Ther. 2025 Jul;31(7):461.e1-461.e12. doi: 10.1016/j.jtct.2025.04.010. Epub 2025 Apr 28. Transplant Cell Ther. 2025. PMID: 40306552
Spiromeroterpenoids from the Higher Plants.
Saito Y, Nishida T, Nakagawa-Goto K. Saito Y, et al. Among authors: nishida t. Chem Pharm Bull (Tokyo). 2025;73(3):138-155. doi: 10.1248/cpb.c24-00733. Chem Pharm Bull (Tokyo). 2025. PMID: 40058821 Free article. Review.
2,973 results